Neuro Pioneers on a Quest to Cure
Menu
Home
Our company
  • Our Story
  • Pipeline
  • People
  • Culture
  • Patients
    • Platform
  • FlexASO® Platform
  • News
  • Presentations and Publications
  • Careers
  • Contact

    • Explore More

    Team
    People
    Pipeline
    Pipeline
    Culture
    Culture
    Patients
    Patients

    Latest Press Releases

    August 24, 2026

    QurAlis to Participate in Upcoming Investor Conferences in September

    February 23, 2026

    QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS

    December 29, 2025

    QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener

    December 18, 2025

    QurAlis Invited to Present at 44th Annual J.P. Morgan Healthcare Conference